CannaPharmaRX, Inc. Stock

CPMD

US13765D1090

Healthcare Facilities & Services

Market Closed - OTC Markets 03:08:17 2026-11-13 pm EST			5-day change	1st Jan Change
0.002000 ^USD	0.00%		0.00%	-61.54%

Aug. 18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Valuation: CannaPharmaRX, Inc.

Market Cap	1.4M 1.27M 1.17M 1.06M 2M 132M 2.07M 14.11M 5.59M 70.57M 5.26M 5.15M 224M	P/E 2024	-0.51x	P/E 2025	-0.31x
Enterprise Value	22.05M 19.98M 18.48M 16.68M 31.42M 2.08B 32.53M 222M 88.03M 1.11B 82.75M 80.99M 3.53B	EV / Sales 2024	23,622,884x	EV / Sales 2025	17,663,843x
Free-Float	92.71%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news: CannaPharmaRX, Inc.

Aug. 18	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 20	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Mar. 31	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 30	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI
Jan. 13	Cannapharmarx, Inc. Announces Resignation of Director Rick Orman, Effective January 8, 2026	CI
Nov. 14	CannaPharmaRX, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-08-19	Cannapharmarx, Inc. Plans to Open Its Sixth Growing Room in September	CI
25-08-19	Cannapharmarx, Inc. Announces Series of Strategic Developments	CI
25-08-19	Cannapharmarx, Inc. Announces Revenue Guidance for Third Quarter 2025	CI
25-08-14	CannaPharmaRX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-16	CannaPharmaRX, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-10	CannaPharmaRX, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-09	CannaPharmaRX, Inc. Auditor Raises 'Going Concern' Doubt	CI

More news

Press Releases: CannaPharmaRX, Inc.

25-05-06	CannapharmaRx Continues into New European Market with First Shipment Completed to Germany	AQ
23-06-23	CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
22-12-22	Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	NE
22-12-21	CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	AQ
22-11-21	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ

More press releases

Managers and Directors: CannaPharmaRX, Inc.

Manager	Title	Age	Since
Constantine Nkafu CEO	Chief Executive Officer	50	2024-09-06
Oliver Foeste DFI	Director of Finance/CFO	50	2023-10-12

Director	Title	Age	Since
Dominick Colvin BRD	Director/Board Member	57	2018-03-31
Anthony Panek BRD	Director/Board Member	41	2023-08-24
Constantine Nkafu BRD	Director/Board Member	50	2025-03-30

More insiders

CannaPharmaRX Inc. is a Canada-based cannabis company focused on producing medical cannabis and craft products. The Company operates from its facility in Cremona, Alberta, Canada and is able to produce over 6,000 kilograms per year. The Company is focused on the acquisition, development, and operation of cannabis cultivation facilities in Canada. The Company produces and sells dried cannabis flower, which is packaged for sale as dried flower and trim shake. It sells dried flowers for medicinal purposes. The Company's products include unique genetics, craft products, medical cannabis, its brands and licenses. Craft cannabis, also known as craft marijuana, is cannabis that is produced on a small scale by artisanal or independent producers.

Employees

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
26-11-13	$0.002000	0.00%	541,833
26-11-12	$0.002000	0.00%	64,471
26-11-10	$0.002000	+25.00%	769,474
26-11-09	$0.001600	-20.00%	530,810
26-11-06	$0.002000	+33.33%	802,000

Delayed Quote OTC Markets

More quotes

3 months	+5.26%
6 months	-47.37%
Current year	-61.54%

1 week	0		0
1 month	0		0
Current year	0		0.01
1 year	0		0.01
3 years	0		0.03
5 years	0		0.05
10 years	0		4

Date	Insider	Type	% Market Cap.	Importance
12/30/25	Amir David Tal	Other	0.0000%	-
12/30/25	Amir David Tal	Other	0.0000%	-
12/30/25	Amir David Tal	Other	0.0000%	-

	2024	2025
Net sales	0.82 0.74 0.69 0.62 1.17 77.33 1.21 8.26 3.27 41.31 3.08 3.01 131.12	1.36 1.23 1.14 1.03 1.94 128.44 2.01 13.72 5.44 68.61 5.11 5 217.78
Net income	-9.91M -8.98M -8.3M -7.49M -14.12M -934M -14.62M -99.74M -39.55M -499M -37.17M -36.38M -1.58B	-11.13M -10.09M -9.33M -8.42M -15.86M -1.05B -16.42M -112M -44.44M -561M -41.77M -40.89M -1.78B
Net Debt	14.06M 12.74M 11.78M 10.63M 20.04M 1.33B 20.74M 142M 56.13M 708M 52.76M 51.64M 2.25B	20.65M 18.71M 17.31M 15.62M 29.43M 1.95B 30.46M 208M 82.44M 1.04B 77.49M 75.84M 3.3B

CannaPharmaRX, Inc. Stock

Stocks

CPMD

US13765D1090

Healthcare Facilities & Services

Valuation: CannaPharmaRX, Inc.

Chart: CannaPharmaRX, Inc.

Latest news: CannaPharmaRX, Inc.

Press Releases: CannaPharmaRX, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: CannaPharmaRX, Inc.

Latest insider transactions

Medical Farming

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CANNAPHARMARX, INC.	0.00%	0.00%	-	-	1.4M
Average	0.00%
Weighted average by Cap.	0.00%